Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production

dc.contributor.authorOlson, Matthew R.
dc.contributor.authorUlrich, Benjamin J.
dc.contributor.authorHummel, Sarah A.
dc.contributor.authorKhan, Ibrahim
dc.contributor.authorMeuris, Brice
dc.contributor.authorCherukur, Yesesri
dc.contributor.authorDent, Alexander L.
dc.contributor.authorJanga, Sarath Chandra
dc.contributor.authorKaplan, Mark H.
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2019-02-18T14:46:26Z
dc.date.available2019-02-18T14:46:26Z
dc.date.issued2017-06-01
dc.description.abstractIL-2 is a pleiotropic cytokine that promotes the differentiation of Th cell subsets, including Th1, Th2, and Th9 cells, but it impairs the development of Th17 and T follicular helper cells. Although IL-2 is produced by all polarized Th subsets to some level, how it impacts cytokine production when effector T cells are restimulated is unknown. We show in this article that Golgi transport inhibitors (GTIs) blocked IL-9 production. Mechanistically, GTIs blocked secretion of IL-2 that normally feeds back in a paracrine manner to promote STAT5 activation and IL-9 production. IL-2 feedback had no effect on Th1- or Th17-signature cytokine production, but it promoted Th2- and Th9-associated cytokine expression. These data suggest that the use of GTIs results in an underestimation of the presence of type 2 cytokine-secreting cells and highlight IL-2 as a critical component in optimal cytokine production by Th2 and Th9 cells in vitro and in vivo.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationOlson, M. R., Ulrich, B. J., Hummel, S. A., Khan, I., Meuris, B., Cherukuri, Y., Dent, A. L., Janga, S. C., … Kaplan, M. H. (2017). Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production. Journal of immunology (Baltimore, Md. : 1950), 198(11), 4352-4359.en_US
dc.identifier.urihttps://hdl.handle.net/1805/18417
dc.language.isoen_USen_US
dc.publisherAmerican Association of Immunologistsen_US
dc.relation.isversionof10.4049/jimmunol.1601792en_US
dc.relation.journalJournal of Immunologyen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectBrefeldin Aen_US
dc.subjectCell Differentiationen_US
dc.subjectCytokinesen_US
dc.subjectInterleukin-2en_US
dc.subjectInterleukin-9en_US
dc.subjectLymphocyte Activationen_US
dc.subjectMice, Inbred C57BLen_US
dc.subjectMonensinen_US
dc.subjectParacrine Communicationen_US
dc.subjectProtein Synthesis Inhibitorsen_US
dc.subjectProton Ionophoresen_US
dc.subjectSTAT5 Transcription Factoren_US
dc.subjectTh1 Cellsen_US
dc.subjectTh17 Cellsen_US
dc.subjectTh2 Cellsen_US
dc.titleParacrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Productionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms866989.pdf
Size:
1021.05 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: